Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels

被引:66
作者
Bartok, Adam [1 ]
Toth, Agnes [1 ]
Somodi, Sandor [2 ]
Szanto, Tibor G. [1 ]
Hajdu, Peter [3 ]
Panyi, Gyorgy [1 ,4 ]
Varga, Zoltan [1 ]
机构
[1] Univ Debrecen, Fac Med, Dept Biophys & Cell Biol, H-4032 Debrecen, Hungary
[2] Univ Debrecen, Dept Internal Med, Div Metab Dis, H-4032 Debrecen, Hungary
[3] Univ Debrecen, Fac Dent, Dept Biophys & Cell Biol, H-4032 Debrecen, Hungary
[4] MTA DE Cell Biol & Signaling Res Grp, H-4032 Debrecen, Hungary
关键词
Margatoxin; MgTx; Non-selective; Kv1.3; Kv1.2; GATED POTASSIUM CHANNELS; ENTERIC NERVOUS-SYSTEM; HUMAN T-LYMPHOCYTES; GUINEA-PIG ILEUM; AUTOIMMUNE-DISEASES; SUBUNIT COMPOSITION; ION CHANNELS; CELLS; PEPTIDE; TOXIN;
D O I
10.1016/j.toxicon.2014.05.002
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Margatoxin (MgTx), an alpha-KTx scorpion toxin, is considered a selective inhibitor of the Kv1.3K + channel. This peptide is widely used in ion channel research; however, a comprehensive study of its selectivity with electrophysiological methods has not been published yet. The lack of selectivity might lead to undesired side effects upon therapeutic application or may lead to incorrect conclusion regarding the role of a particular ion channel in a physiological or pathophysiological response either in vitro or in vivo. Using the patch-clamp technique we characterized the selectivity profile of MgTx using L929 cells expressing mKv1.1 channels, human peripheral lymphocytes expressing Kv1.3 channels and transiently transfected tsA201 cells expressing hKv1.1, hKv1.2, hKv1.3, hKv1.4-IR, hKv1.5, hKv1.6, hKv1.7, rKv2.1, Shaker-IR, hERG, hKCa1.1, hKCa3.1 and hNav1.5 channels. MgTx is indeed a high affinity inhibitor of Kv1.3 (Kd = 11.7 pM) but is not selective, it inhibits the Kv1.2 channel with similar affinity (Kd = 6.4 pM) and Kv1.1 in the nanomolar range (Kd = 4.2 nM). Based on our comprehensive data MgTX has to be considered a non-selective Kv1.3 inhibitor, and thus, experiments aiming at elucidating the significance of Kv13 in in vitro or in vivo physiological responses have to be carefully evaluated. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6 / 16
页数:11
相关论文
共 64 条
[1]
Molecular mechanisms of cardiac voltage-gated potassium channelopathies [J].
Abbott, Geoffrey W. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (28) :3631-3644
[2]
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of KV1.3 Channel Blockers [J].
Anangi, Raveendra ;
Koshy, Shyny ;
Huq, Redwan ;
Beeton, Christine ;
Chuang, Woei-Jer ;
King, Glenn F. .
PLOS ONE, 2012, 7 (12)
[3]
ARKETT SA, 1994, RECEPTOR CHANNEL, V2, P281
[4]
Stimulatory action of internal protons on Slo1 BK channels [J].
Avdonin, V ;
Tang, XD ;
Hoshi, T .
BIOPHYSICAL JOURNAL, 2003, 84 (05) :2969-2980
[5]
Anuroctoxin, a new scorpion toxin of the α-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes [J].
Bagdány, M ;
Batista, CVF ;
Valdez-Cruz, NA ;
Somodi, A ;
de la Vega, RCR ;
Licea, AF ;
Varga, Z ;
Gáspár, R ;
Possani, LD ;
Panyi, G .
MOLECULAR PHARMACOLOGY, 2005, 67 (04) :1034-1044
[6]
Voltage-gated K+ channel (Kv) subunit expression of the guinea pig spiral ganglion cells studied in a newly developed cochlear free-floating preparation [J].
Bakondi, Gabor ;
Por, Agnes ;
Kovacs, Ilona ;
Szucs, Gza ;
Rusznak, Zoltan .
BRAIN RESEARCH, 2008, 1210 :148-162
[7]
Scorpion Toxins Specific for Potassium (K+) Channels: A Historical Overview of Peptide Bioengineering [J].
Bergeron, Zachary L. ;
Bingham, Jon-Paul .
TOXINS, 2012, 4 (11) :1082-1119
[8]
EPISODIC ATAXIA MYOKYMIA SYNDROME IS ASSOCIATED WITH POINT MUTATIONS IN THE HUMAN POTASSIUM CHANNEL GENE, KCNA1 [J].
BROWNE, DL ;
GANCHER, ST ;
NUTT, JG ;
BRUNT, ERP ;
SMITH, EA ;
KRAMER, P ;
LITT, M .
NATURE GENETICS, 1994, 8 (02) :136-140
[9]
K+ channels as targets for specific immunomodulation [J].
Chandy, KG ;
Wulff, H ;
Beeton, C ;
Pennington, M ;
Gutman, GA ;
Cahalan, MD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (05) :280-289
[10]
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases [J].
Chi, Victor ;
Pennington, Michael W. ;
Norton, Raymond S. ;
Tarcha, Eric J. ;
Londono, Luz M. ;
Sims-Fahey, Brian ;
Upadhyay, Sanjeev K. ;
Lakey, Jonathan T. ;
Iadonato, Shawn ;
Wulff, Heike ;
Beeton, Christine ;
Chandy, K. George .
TOXICON, 2012, 59 (04) :529-546